Robert Harris, MD
Gynecology · Flowood, MSNPI 1982641189
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Axonics, Inc. accounts for 75.5% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2022 at $6,890 and has fallen 78.9% since, to $1,457 in 2025.
Across 211 payments — averaging $82.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$13K
- Boston Scientific$1K
- Caldera Medical, Inc$800
- Astellas Pharma US Inc$515
- AbbVie$412
- Sumitomo Pharma America, Inc.$228
- plus $807 from 20 others
What the payments were for
- Consulting fees$6,25036%
- Speaking & faculty fees$1161%
- Travel & lodging$2,22413%
- Food & beverage$8,45449%
- Education$1531%
- Gifts$1341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 92 | $13,090 |
| Boston Scientific | 14 | $1,477 |
| Caldera Medical, Inc | 9 | $800 |
| Astellas Pharma US Inc | 24 | $515 |
| AbbVie(2 entities) | 29 | $412 |
| Sumitomo Pharma America, Inc. | 12 | $228 |
| Medtronic | 3 | $199 |
| Skeletal Dynamics Inc | 1 | $101 |
| Intuitive Surgical | 1 | $85 |
| Therapeuticsmd, Inc. | 5 | $72 |
| Urovant Sciences Inc | 2 | $39 |
| Rochester Medical Corporation | 2 | $38 |
| Coloplast | 2 | $35 |
| Pfizer | 2 | $26 |
| AMAG Pharmaceuticals, Inc. | 2 | $26 |
| Hologic Sales And Service, LLC | 1 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Si-bone, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Novo Nordisk | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Dentsply IH Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$7,487
- Axonics r-SNM System$3,821
- Bulkamid$1,012
- Desara$530
- Solyx SIS System$453
- PERCUTANEOUS TRACT KIT$145
- UPSYLON$115
- Geminus$101
- Align$101
- IJS$101
- Implate$101
How this compares
Too few gynecology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 71 | $49,791 |
| MyrbetriqMirabegron | 38 | $20,278 |
| Estradiol | 124 | $8,375 |
| NitrofurantoinNitrofurantoin Macrocrystal | 71 | $1,331 |
| Estradiol (Once Weekly)Estradiol | 13 | $505 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $295 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 51 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $228 | $49,79171 claims |
| Astellas Pharma US IncMyrbetriq | $515 | $20,27838 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few gynecology providers in Mississippion file to place this against a meaningful peer group, so we don't.
Other gynecology in Flowood
- Natasha HardemanFlowood$4K
- Lindsey TurnerFlowood$3K
- Mercer LeeFlowood$277
- Laura DailyJackson$4K
- Jermaine GrayJackson$3K
- Carl ReddixJackson$784
- Thomas LehmanGulfport$548
- Haley McCoolGulfport$546
- Sr EvansGreenwood$406
- Ej PriceMcComb$103
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.